Tamoxifen therapy benefit for patients with 70-gene signature high and low risk von van ‘t Veer, Laura J., Yau, Christina, Yu, Nancy Y., Benz, Christopher C., Nordenskjöld, Bo, Fornander, Tommy, Stål, Olle, Esserman, Laura J., Lindström, Linda Sofie

Volltext

A prospective evaluation of a breast cancer prognosis signature in the observational RASTER study von Drukker, C.A., Bueno‐de‐Mesquita, J.M., Retèl, V.P., Harten, W.H., Tinteren, H., Wesseling, J., Roumen, R.M.H., Knauer, M., Veer, L.J., Sonke, G.S., Rutgers, E.J.T., Vijver, M.J., Linn, S.C.

Volltext

Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies von YANG, Xiaohong R, CHANG-CLAUDE, Jenny, FASCHING, Peter A, HEIN, Rebecca, SPURDLE, Amanda B, BLOWS, Fiona, DRIVER, Kristy, FLESCH-JANYS, Dieter, HEINZ, Judith, SINN, Peter, VRIELING, Alina, HEIKKINEN, Tuomas, GOODE, Ellen L, AITTOMÄKI, Kristiina, HEIKKILÄ, Paivi, BLOMQVIST, Carl, LISSOWSKA, Jolanta, PEPLONSKA, Beata, CHANOCK, Stephen, FIGUEROA, Jonine, BRINTON, Louise, HALL, Per, CZENE, Kamila, COUCH, Fergus J, HUMPHREYS, Keith, DARABI, Hatef, JIANJUN LIU, VAN 'T VEER, Laura J, VAN LEEUWEN, Flora E, ANDRULIS, Irene L, GLENDON, Gord, KNIGHT, Julia A, MULLIGAN, Anna Marie, O'MALLEY, Frances P, NEVANLINNA, Heli, WEERASOORIYA, Nayana, JOHN, Esther M, BECKMANN, Matthias W, HARTMANN, Arndt, WEIHBRECHT, Sebastian B, WACHTER, David L, JUD, Sebastian M, LOEHBERG, Christian R, BAGLIETTO, Laura, ENGLISH, Dallas R, MILNE, Roger L, GILES, Graham G, MCLEAN, Catriona A, SEVERI, Gianluca, LAMBRECHTS, Diether, VANDORPE, Thijs, WELTENS, Caroline, PARIDAENS, Robert, SMEETS, Ann, NEVEN, Patrick, GAUDET, Mia, SCHMIDT, Marjanka K, BROEKS, Annegien, COX, Angela

Volltext

Gene expression profiling predicts clinical outcome of breast cancer von Friend, Stephen H, van 't Veer, Laura J, Dai, Hongyue, van de Vijver, Marc J, He, Yudong D, Hart, Augustinus A. M, Mao, Mao, Peterse, Hans L, van der Kooy, Karin, Marton, Matthew J, Witteveen, Anke T, Schreiber, George J, Kerkhoven, Ron M, Roberts, Chris, Linsley, Peter S, Bernards, René

Volltext

Associations of a Breast Cancer Polygenic Risk Score With Tumor Characteristics and Survival von Lopes Cardozo, Josephine M N, Andrulis, Irene L, Bojesen, Stig E, Dörk, Thilo, Eccles, Diana M, Fasching, Peter A, Hooning, Maartje J, Keeman, Renske, Nevanlinna, Heli, Rutgers, Emiel J T, Easton, Douglas F, Hall, Per, Pharoah, Paul D P, van 't Veer, Laura J, Schmidt, Marjanka K

Volltext

A Gene-Expression Signature as a Predictor of Survival in Breast Cancer von van de Vijver, Marc J, He, Yudong D, van 't Veer, Laura J, Dai, Hongyue, Hart, Augustinus A.M, Voskuil, Dorien W, Schreiber, George J, Peterse, Johannes L, Roberts, Chris, Marton, Matthew J, Parrish, Mark, Atsma, Douwe, Witteveen, Anke, Glas, Annuska, Delahaye, Leonie, van der Velde, Tony, Bartelink, Harry, Rodenhuis, Sjoerd, Rutgers, Emiel T, Friend, Stephen H, Bernards, René

Volltext

Abstract P4-12-01: MammaPrint is cost-effective compared to clinical risk assessment in early stage breast cancer von Retèl, VP, Joore, MA, van 't Veer, LJ, Cardoso, F, Piccart, MJ, Rutgers, EJ, Tryfonidis, K, Poncet, C, van Harten, WH

Volltext

Abstract P3-08-02: Multi-gene panel testing for hereditary cancer predisposition in unsolved high risk breast and ovarian cancer patients von Crawford, BB, Adams, SB, Sittler, T, Van den Akker, J, Chan, SB, Leitner, O, Ryan, LN, Gil, E, Van 't Veer, LJ

Volltext

Abstract OT2-08-01: Personalized breast cancer screening in a population based study: Women Informed to Screen Depending On Measures of risk (WISDOM) von Acerbi, I, Shieh, Y, Madlensky, L, Tice, J, Ziv, E, Eklund, M, Blanco, A, DeRosa, D, Tong, B, Goodman, D, Nassereddine, L, Anderson, N, Harvey, H, Layton, T, Park, HL, Petruse, A, Stewart, S, Wernisch, J, Risty, L, Koenig, B, Sarrafan, S, Firouzian, R, Kaplan, C, Hiatt, R, Parker, BA, Wenger, N, Lee, V, Heditsian, D, Brain, S, Stover Fiscalini, A, Borowsky, AD, Anton-Culver, H, Naeim, A, Kaster, A, Talley, M, van 't Veer, LJ, LaCroix, A, Esserman, LJ

Volltext

Abstract PD7-01: Can surrogate pathological subtyping replace molecular subtyping? Outcome results from the MINDACT trial von Cardoso, F, Slaets, L, de Snoo, F, Bogaerts, J, van 't Veer, LJ, Rutgers, EJ, Piccart-Gebhart, MJ, Stork-Sloots, L, Russo, L, Dell'Orto, P, Viale, G

Volltext

Abstract P6-09-01: Identification of tumors with an indolent disease course: MammaPrint ultralow signature validation in a retrospective analysis of a Swedish randomized tamoxifen... von Esserman, LJ, Thompson, CK, Yau, C, van 't Veer, LJ, Borowsky, AD, Tobin, NP, Nordenskjöld, B, Fornander, T, Stål, O, Benz, CC, Lindström, LS

Volltext

Expression profiling predicts outcome in breast cancer von van 't Veer, Laura J, Dai, Hongyue, van de Vijver, Marc J, He, Yudong D, Hart, Augustinus A M, Bernards, René, Friend, Stephen H

Volltext

ATM germline mutations in classical ataxia-telangiectasia patients in the Dutch population von Broeks, A, de Klein, A, Floore, AN, Muijtjens, M, Kleijer, WJ, Jaspers, NG, van 't Veer, LJ

Volltext

Abstract P6-06-13: Optimized prediction of clinical outcome by the PREDICT plus tool and the 70-gene signature in early stage node-negative breast cancer von Drukker, CA, Nijenhuis, MV, Bueno-de-Mesquita, JM, Retel, VP, van Tinteren, H, Schmidt, MK, van Harten, WH, Sonke, GS, van 't Veer, LJ, Rutgers, EJ, van de Vijver, MJ, Linn, SC

Volltext

P5-01-05: Activating Mutations in PIK3CA or AKT1 in the I-SPY 1 Trial (CALGB 150007/150012; ACRIN 6657) von Boudreau, A, Yau, C, Petrillo, L, Stemke-Hale, K, Mills, GB, Gray, JW, Wolf, DM, van ‘t Veer, LJ

Volltext

Personalized breast cancer screening in a population based study: Women Informed to Screen Depending On Measures of risk (WISDOM) von Acerbi, I, Shieh, Y, Madlensky, L, Tice, J, Ziv, E, Eklund, M, Blanco, A, DeRosa, D, Tong, B, Goodman, D, Nassereddine, L, Anderson, N, Harvey, H, Layton, T, Park, HL, Petruse, A, Stewart, S, Wernisch, J, Risty, L, Koenig, B, Sarrafan, S, Firouzian, R, Kaplan, C, Hiatt, R, Parker, BA, Wenger, N, Lee, V, Heditsian, D, Brain, S, Fiscalini, AS, Borowsky, AD, Anton-Culver, H, Naeim, A, Kaster, A, Talley, M, Van 't Veer, LJ, LaCroix, A, Esserman, LJ

Volltext

Expression profiling as a prognostic and predictive factor in breast cancer von van 't Veer, LJ

Volltext

E2F-5, a new E2F family member that interacts with p130 in vivo von Hijmans, E. Marielle, Voorhoeve, P. Mathijs, Beijersbergen, Roderick L., van 't Veer, Laura J., Bernards, René

Volltext

Insulin-like growth factor (IGF)-system mRNA quantities in normal and tumor breast tissue of women with sporadic and familial breast cancer risk von VOSKUIL, Dorien W, BOSMA, Astrid, VRIELING, Alina, ROOKUS, Matti A, VAN'T VEER, Laura J

Volltext

The 70-gene prognosis profile predicts early metastases in postmenopausal breast cancer patients von Mook, S, Schmidt, MK, Weigelt, B, Kreike, B, Eekhout, I, Glas, AM, Floore, AN, Rutgers, EJ, Van 't Veer, LJ

Volltext